159 related articles for article (PubMed ID: 12542483)
1. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis.
Núñez-López R; Escribano L; Schernthaner GH; Prados A; Rodríguez-González R; Díaz-Agustín B; López A; Hauswirth A; Valent P; Almeida J; Bravo P; Orfao A
Br J Haematol; 2003 Jan; 120(2):257-65. PubMed ID: 12542483
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow.
Jabbar KJ; Medeiros LJ; Wang SA; Miranda RN; Johnson MR; Verstovsek S; Jorgensen JL
Arch Pathol Lab Med; 2014 Sep; 138(9):1210-4. PubMed ID: 25171703
[TBL] [Abstract][Full Text] [Related]
5. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.
Escribano L; Orfao A; Díaz-Agustin B; Villarrubia J; Cerveró C; López A; Marcos MA; Bellas C; Fernández-Cañadas S; Cuevas M; Sánchez A; Velasco JL; Navarro JL; Miguel JF
Blood; 1998 Apr; 91(8):2731-6. PubMed ID: 9531582
[TBL] [Abstract][Full Text] [Related]
6. X-irradiation does not affect the levels of complement regulatory proteins, CD35 (CR1), CD55 (DAF) and CD59 on concentrated red cells.
Fukumori Y; Seya T; Ohnoki S; Shibata H; Yamaguchi H
Vox Sang; 1996; 71(4):243-4. PubMed ID: 8958650
[No Abstract] [Full Text] [Related]
7. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell surface antigens on mast cells: mast cell phenotyping.
Hauswirth AW; Florian S; Schernthaner GH; Krauth MT; Sonneck K; Sperr WR; Valent P
Methods Mol Biol; 2006; 315():77-90. PubMed ID: 16110150
[TBL] [Abstract][Full Text] [Related]
9. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
10. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.
Teodosio C; García-Montero AC; Jara-Acevedo M; Sánchez-Muñoz L; Alvarez-Twose I; Núñez R; Schwartz LB; Walls AF; Escribano L; Orfao A
J Allergy Clin Immunol; 2010 Mar; 125(3):719-26, 726.e1-726.e4. PubMed ID: 20061010
[TBL] [Abstract][Full Text] [Related]
11. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
Amara U; Kalbitz M; Perl M; Flierl MA; Rittirsch D; Weiss M; Schneider M; Gebhard F; Huber-Lang M
Shock; 2010 Jun; 33(6):568-75. PubMed ID: 19864971
[TBL] [Abstract][Full Text] [Related]
12. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease.
Díaz-Agustín B; Escribano L; Bravo P; Herrero S; Nuñez R; Navalón R; Navarro L; Torrelo A; Cantalapiedra A; Del Castillo L; Villarrubia J; Navarro JL; San Miguel JF; Orfao A
Br J Haematol; 1999 Aug; 106(2):400-5. PubMed ID: 10460598
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.
Escribano L; Orfao A; Villarrubia J; Díaz-Agustín B; Cerveró C; Rios A; Velasco JL; Ciudad J; Navarro JL; San Miguel JF
Anal Cell Pathol; 1998; 16(3):151-9. PubMed ID: 9699944
[TBL] [Abstract][Full Text] [Related]
14. CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disorders.
Santos DD; Hatjiharissi E; Tournilhac O; Chemaly MZ; Leleu X; Xu L; Patterson C; Branagan AR; Manning RJ; Ho AW; Hunter ZR; Dimmock EA; Kutok JL; Churchill WH; Castells MC; Tai YT; Anderson KC; Treon SP
Clin Lymphoma Myeloma; 2006 May; 6(6):478-83. PubMed ID: 16796779
[TBL] [Abstract][Full Text] [Related]
15. Complement-regulatory proteins in ovarian malignancies.
Bjørge L; Hakulinen J; Wahlström T; Matre R; Meri S
Int J Cancer; 1997 Jan; 70(1):14-25. PubMed ID: 8985085
[TBL] [Abstract][Full Text] [Related]
16. Indolent systemic mast cell disease: immunophenotypic characterization of bone marrow mast cells by flow cytometry.
Bodni RA; Sapia S; Galeano A; Kaminsky A
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):160-6. PubMed ID: 12705744
[TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.
Dasilva-Freire N; Mayado A; Teodosio C; Jara-Acevedo M; Álvarez-Twose I; Matito A; Sánchez-Muñoz L; Caldas C; Henriques A; Muñoz-González JI; García-Montero AC; Sánchez-Gallego JI; Escribano L; Orfao A
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696068
[TBL] [Abstract][Full Text] [Related]
18. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
19. An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.
Teodosio C; García-Montero AC; Jara-Acevedo M; Alvarez-Twose I; Sánchez-Muñoz L; Almeida J; Morgado JM; Matito A; Escribano L; Orfao A
Leukemia; 2012 May; 26(5):951-8. PubMed ID: 22051531
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
Escribano L; Diaz-Agustin B; López A; Núñez López R; García-Montero A; Almeida J; Prados A; Angulo M; Herrero S; Orfao A;
Cytometry B Clin Cytom; 2004 Mar; 58(1):1-8. PubMed ID: 14994369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
